11
Tue, May

world malaria day

  • ASAAP leads the way in assessing the viability of a triple therapy antimalarial via a multicenter clinical trial. Triple therapy is expected to significantly slow down the rate at which resistance of malaria parasites to medication develops.

    Seven reputable institutions across Sub-Saharan Africa, Germany, and France have come together to run the project ASAAP - Clinical evaluation of ArteSunate+Amodiaquine+Atovaquone-Proguanil tri-therapy for malaria treatment in African children. ASAAP is a 48-month-long multicenter clinical trial, coordinated by the Kumasi Center for Collaborative Research in Tropical Medicine (KCCR).

  • So, how about malaria vaccines? Can the rapid interest in life-saving COVID-19 vaccines spur world scientists on to get us malaria vaccines in record time?

    Good news, as the world works progressively towards COVID-19 vaccines and their administration. Currently, the global figures, one year since the outbreak of the disease, is reportedly a little over 110 million cases of which close to 62 million have recovered and about 2.44 million have died.

  • There have been calls for investment in the local production of vaccines not only for COVID-19 but others as well for routine immunization. Vaccine production is capital intensive and has always been the preserve of the northern countries, the Western world and Europe due to their financial clout and support from moguls.

    Written By Theresa Owusu Ako - Ghana is hosting this year’s launch of Africa Vaccination Week. An event celebrated during the last week of April 24th -30th with other WHO Regions and the World Immunization week. The week aims at promoting the use of vaccines to protect people of all ages. The continuous search for a long lasting COVID-19 vaccine brings to the fore the importance of vaccines to human existence from birth to adulthood. Many dangerous diseases can be prevented through the use of vaccines. Some of these are Polio, Measles, Yellow Fever, Malaria, TB and a host of others including COVID-19. Ghana has been chosen to host this year’s event in recognition of its high immunisation status with consistent high coverage rates, commitment of leadership, successes in sustaining routine immunization during the peak of the COVID-19 pandemic and being the first country within Africa to access and deploy COVID-19 vaccines through the COVAX facility.

  • The workers will be trained to use larviciding, an insecticide that is specifically targeted at the larval life stage of an insect, particularly the mosquito, as part of the National Malaria Control Programme .

    A nationwide training programme to equip more than 10,000 personnel in the health sector to combat malaria has began.

Sign up via our free email subscription service to receive notifications when new information is available.